Cannabinoides
Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Universitario La Paz (5)
2020
-
Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from von Hippel–Lindau disease
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-30
2019
-
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872
-
Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)
Proceedings of the National Academy of Sciences of the United States of America
2018
-
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2ˉ· production in cancer cells
British Journal of Cancer, Vol. 119, Núm. 8, pp. 994-1008
2011
-
Pharmacological targeting of the transcription factor NRf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism
Antioxidants and Redox Signaling, Vol. 14, Núm. 12, pp. 2347-2360